canthaxanthin has been researched along with Urinary Bladder Neoplasms in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 2 (100.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Kojima, T; Mori, H; Morishita, Y; Okumura, A; Suzui, M; Tanaka, T | 1 |
| Drouin, G; Krinsky, NI; Lausen, N; Mathews-Roth, MM; Richter, A | 1 |
2 other study(ies) available for canthaxanthin and Urinary Bladder Neoplasms
| Article | Year |
|---|---|
Chemoprevention of mouse urinary bladder carcinogenesis by the naturally occurring carotenoid astaxanthin.
Topics: Animals; Anticarcinogenic Agents; beta Carotene; Body Weight; Butylhydroxybutylnitrosamine; Canthaxanthin; Carotenoids; Liver; Male; Mice; Mice, Inbred ICR; Nucleolus Organizer Region; Organ Size; Precancerous Conditions; Silver Staining; Urinary Bladder Neoplasms; Xanthophylls | 1994 |
Effects of carotenoid administration on bladder cancer prevention.
Topics: Animals; Antioxidants; Butylhydroxybutylnitrosamine; Canthaxanthin; Carcinoma, Transitional Cell; Carotenoids; Male; Mice; Placebos; Urinary Bladder Neoplasms | 1991 |